BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta
41 results:

  • 1. Pan-Cancer Interrogation of
    Paller CJ; Tukachinsky H; Maertens A; Decker B; Sampson JR; Cheadle JP; Antonarakis ES
    JCO Precis Oncol; 2024 Feb; 8():e2300251. PubMed ID: 38394468
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. First report of medulloblastoma in a patient with mutyh-associated polyposis.
    Villy MC; Warcoin M; Filser M; Buecher B; Golmard L; Suybeng V; Schwartz M; Bieche I; Vacher S; Laurence V; Bourdeaut F; Bernier M; Gutman T; Stoppa-Lyonnet D; Masliah-Planchon J; Colas C
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12929. PubMed ID: 37524406
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Venizelos A; Sorbye H; Elvebakken H; Perren A; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Vestermark LW; Ladekarl M; Tabaksblat EM; Knappskog S
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37410378
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
    Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. New pathogenic germline variants identified in mesothelioma.
    Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
    Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
    Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
    BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. germline mutyh mutations and high-grade gliomas: Novel evidence for a potential association.
    Bedics G; Kotmayer L; Zajta E; Hegyi LL; Brückner EÁ; Rajnai H; Reiniger L; Bödör C; Garami M; Scheich B
    Genes Chromosomes Cancer; 2022 Oct; 61(10):622-628. PubMed ID: 35545820
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mismatch repair deficiency and mutyh variants in small intestine-neuroendocrine tumors.
    Helderman NC; Elsayed FA; van Wezel T; Terlouw D; Langers AMJ; van Egmond D; Kilinç G; Hristova H; Farina Sarasqueta A; Morreau H; Nielsen M; Suerink M;
    Hum Pathol; 2022 Jul; 125():11-17. PubMed ID: 35417733
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification.
    Ishida H; Lam AK
    Crit Rev Oncol Hematol; 2022 Apr; 172():103648. PubMed ID: 35248713
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Implications of Pathogenic germline Variants in Small Intestine Neuroendocrine tumors (SI-NETs).
    Perez K; Kulke MH; Chittenden A; Ukaegbu C; Astone K; Alexander H; Brais L; Zhang J; Garcia J; Esplin ED; Yang S; Da Silva A; Nowak JA; Yurgelun MB; Garber J; Syngal S; Chan J
    JCO Precis Oncol; 2021 Nov; 5():808-816. PubMed ID: 34994613
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Monoallelic deleterious mutyh germline variants as a driver for tumorigenesis.
    Barreiro RAS; Sabbaga J; Rossi BM; Achatz MIW; Bettoni F; Camargo AA; Asprino PF; A F Galante P
    J Pathol; 2022 Feb; 256(2):214-222. PubMed ID: 34816434
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma.
    van den Boogaard ML; Oka R; Hakkert A; Schild L; Ebus ME; van Gerven MR; Zwijnenburg DA; Molenaar P; Hoyng LL; Dolman MEM; Essing AHW; Koopmans B; Helleday T; Drost J; van Boxtel R; Versteeg R; Koster J; Molenaar JJ
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34479993
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. 'You cannot expect miracles to happen overnight': patience pays off when you wish to establish a new adrenocortical carcinoma cell line.
    Lalli E
    Eur J Endocrinol; 2021 Jul; 185(2):C9-C11. PubMed ID: 34096882
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline mutyh mutation and high tumour mutational burden.
    Landwehr LS; Schreiner J; Appenzeller S; Kircher S; Herterich S; Sbiera S; Fassnacht M; Kroiss M; Weigand I
    Eur J Endocrinol; 2021 May; 184(6):823-835. PubMed ID: 33830941
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.
    Boulouard F; Kasper E; Buisine MP; Lienard G; Vasseur S; Manase S; Bahuau M; Barouk Simonet E; Bubien V; Coulet F; Cusin V; Dhooge M; Golmard L; Goussot V; Hamzaoui N; Lacaze E; Lejeune S; Mauillon J; Beaumont MP; Pinson S; Tlemsani C; Toulas C; Rey JM; Uhrhammer N; Bougeard G; Frebourg T; Houdayer C; Baert-Desurmont S
    Clin Genet; 2021 May; 99(5):662-672. PubMed ID: 33454955
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
    Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C
    Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of Genomic Alterations in Sporadic Pancreatic Neurogenic tumors.
    Wang XY; Cai JP; Song LL; Huang CS; Chen W; Huang XT; Chen SF; Liu XY; Yin XY
    Pancreas; 2020; 49(10):1393-1397. PubMed ID: 33122531
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of Prognostic Signatures of Alternative Splicing in Glioma.
    Zeng Y; Zhang P; Wang X; Wang K; Zhou M; Long H; Lin J; Wu Z; Gao L; Song Y
    J Mol Neurosci; 2020 Oct; 70(10):1484-1492. PubMed ID: 32602029
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
    Pipinikas CP; Berner AM; Sposito T; Thirlwell C
    Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.